The University of Chicago Header Logo

Connection

Maria-Luisa Alegre to Lymphocyte Activation

This is a "connection" page, showing publications Maria-Luisa Alegre has written about Lymphocyte Activation.
Connection Strength

2.723
  1. DC Metabolism Controls Lung T Cell Polarization. Am J Transplant. 2018 02; 18(2):285.
    View in: PubMed
    Score: 0.493
  2. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice. J Immunol. 2004 Nov 01; 173(9):5415-24.
    View in: PubMed
    Score: 0.197
  3. Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. J Immunol. 2001 Mar 15; 166(6):3900-7.
    View in: PubMed
    Score: 0.153
  4. T Cell Receptor-Regulated TGF-ß Type I Receptor Expression Determines T Cell Quiescence and Activation. Immunity. 2018 04 17; 48(4):745-759.e6.
    View in: PubMed
    Score: 0.125
  5. Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation. 2017 11; 101(11):2671-2681.
    View in: PubMed
    Score: 0.121
  6. Antigen Presentation in Transplantation. Trends Immunol. 2016 12; 37(12):831-843.
    View in: PubMed
    Score: 0.113
  7. Adoptive Transfer of Tracer-Alloreactive CD4+ T Cell Receptor Transgenic T Cells Alters the Endogenous Immune Response to an Allograft. Am J Transplant. 2016 10; 16(10):2842-2853.
    View in: PubMed
    Score: 0.109
  8. Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice. Am J Transplant. 2016 10; 16(10):2854-2864.
    View in: PubMed
    Score: 0.109
  9. High-Fat Diet-Induced Obesity Enhances Allograft Rejection. Transplantation. 2016 05; 100(5):1015-21.
    View in: PubMed
    Score: 0.109
  10. Analysis of GzmbCre as a Model System for Gene Deletion in the Natural Killer Cell Lineage. PLoS One. 2015; 10(4):e0125211.
    View in: PubMed
    Score: 0.102
  11. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014 Nov 20; 41(5):830-42.
    View in: PubMed
    Score: 0.098
  12. Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev. 2014 Mar; 258(1):80-101.
    View in: PubMed
    Score: 0.094
  13. Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells. Proc Natl Acad Sci U S A. 2009 Feb 10; 106(6):1909-14.
    View in: PubMed
    Score: 0.066
  14. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol. 2008 Apr; 28(7):2470-80.
    View in: PubMed
    Score: 0.062
  15. Overexpression of program death-1 in T cells has mild impact on allograft survival. Transpl Int. 2008 Jan; 21(1):21-9.
    View in: PubMed
    Score: 0.061
  16. Epidermal Langerhans cells promote skin allograft rejection in mice with NF-kappa B-impaired T cells. Am J Transplant. 2008 Jan; 8(1):21-31.
    View in: PubMed
    Score: 0.061
  17. Costimulatory molecules as targets for the induction of transplantation tolerance. Curr Mol Med. 2006 Dec; 6(8):843-57.
    View in: PubMed
    Score: 0.057
  18. Mechanisms of CTLA-4-Ig in tolerance induction. Curr Pharm Des. 2006; 12(2):149-60.
    View in: PubMed
    Score: 0.053
  19. The balance of immune responses: costimulation verse coinhibition. J Mol Med (Berl). 2005 Mar; 83(3):193-202.
    View in: PubMed
    Score: 0.050
  20. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol. 2004 Dec 15; 173(12):7135-9.
    View in: PubMed
    Score: 0.050
  21. Formation of a central supramolecular activation cluster is not required for activation of naive CD8+ T cells. Proc Natl Acad Sci U S A. 2004 Jun 22; 101(25):9351-6.
    View in: PubMed
    Score: 0.048
  22. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism. J Immunol. 2002 Sep 01; 169(5):2451-9.
    View in: PubMed
    Score: 0.042
  23. Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cells. J Immunol. 2002 Jul 15; 169(2):633-7.
    View in: PubMed
    Score: 0.042
  24. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol. 2001 Dec; 1(3):220-8.
    View in: PubMed
    Score: 0.040
  25. Transplantation and the CD28/CTLA4/B7 pathway. Transplant Proc. 2001 Feb-Mar; 33(1-2):209-11.
    View in: PubMed
    Score: 0.038
  26. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J Immunol. 1997 Jul 01; 159(1):144-51.
    View in: PubMed
    Score: 0.030
  27. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant. 2016 08; 16(8):2312-23.
    View in: PubMed
    Score: 0.027
  28. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015 Nov 27; 350(6264):1084-9.
    View in: PubMed
    Score: 0.026
  29. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. J Immunol. 1995 Aug 01; 155(3):1544-55.
    View in: PubMed
    Score: 0.026
  30. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol. 1994 Sep 15; 153(6):2738-49.
    View in: PubMed
    Score: 0.024
  31. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation. 1994 Jun 15; 57(11):1537-43.
    View in: PubMed
    Score: 0.024
  32. Basal NF-?B controls IL-7 responsiveness of quiescent naïve T cells. Proc Natl Acad Sci U S A. 2014 May 20; 111(20):7397-402.
    View in: PubMed
    Score: 0.024
  33. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody. J Immunol. 1992 Jun 01; 148(11):3461-8.
    View in: PubMed
    Score: 0.021
  34. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol. 2000 Dec 01; 165(11):6606-11.
    View in: PubMed
    Score: 0.009
  35. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J Immunol. 1999 Feb 01; 162(3):1270-7.
    View in: PubMed
    Score: 0.008
  36. Bioactivity of recombinant feline interleukin-2 on human and feline leukocytes. Vet Immunol Immunopathol. 1995 Sep; 48(1-2):27-33.
    View in: PubMed
    Score: 0.007
  37. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. J Immunol. 1992 May 01; 148(9):2756-63.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.